Union Bancaire Privee UBP SA Purchases 14,928 Shares of Oracle Corporation $ORCL

Union Bancaire Privee UBP SA boosted its position in shares of Oracle Corporation (NYSE:ORCL) by 4.4% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 356,056 shares of the enterprise software provider’s stock after acquiring an additional 14,928 shares during the period. Oracle accounts for about 1.6% of Union Bancaire Privee UBP SA’s investment portfolio, making the stock its 15th largest position. Union Bancaire Privee UBP SA’s holdings in Oracle were worth $77,845,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Legend Financial Advisors Inc. bought a new stake in shares of Oracle during the second quarter valued at approximately $34,000. Redmont Wealth Advisors LLC bought a new stake in shares of Oracle during the first quarter valued at approximately $27,000. Inlight Wealth Management LLC bought a new stake in shares of Oracle during the first quarter valued at approximately $28,000. Iron Horse Wealth Management LLC raised its position in shares of Oracle by 284.9% during the first quarter. Iron Horse Wealth Management LLC now owns 204 shares of the enterprise software provider’s stock valued at $29,000 after buying an additional 151 shares during the last quarter. Finally, Family Legacy Financial Solutions LLC bought a new stake in shares of Oracle during the second quarter valued at approximately $60,000. Institutional investors own 42.44% of the company’s stock.

Insider Activity

In other news, insider Michael D. Sicilia sold 33,845 shares of the business’s stock in a transaction on Tuesday, September 23rd. The shares were sold at an average price of $321.16, for a total transaction of $10,869,660.20. Following the completion of the sale, the insider directly owned 132,656 shares of the company’s stock, valued at approximately $42,603,800.96. The trade was a 20.33% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Naomi O. Seligman sold 3,303 shares of the company’s stock in a transaction dated Wednesday, July 16th. The stock was sold at an average price of $233.32, for a total transaction of $770,655.96. Following the completion of the sale, the director directly owned 31,447 shares of the company’s stock, valued at approximately $7,337,214.04. This trade represents a 9.51% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 112,092 shares of company stock valued at $32,960,165. Insiders own 42.20% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently issued reports on ORCL. JPMorgan Chase & Co. lifted their price objective on shares of Oracle from $185.00 to $210.00 and gave the company a “neutral” rating in a research report on Monday, September 8th. Morgan Stanley boosted their price target on shares of Oracle from $246.00 to $320.00 and gave the stock an “equal weight” rating in a research report on Tuesday, September 23rd. Piper Sandler boosted their price target on shares of Oracle from $270.00 to $330.00 and gave the stock an “overweight” rating in a research report on Wednesday, September 10th. Cantor Fitzgerald boosted their price target on shares of Oracle from $271.00 to $400.00 and gave the stock an “overweight” rating in a research report on Wednesday, September 10th. Finally, Raymond James Financial restated a “strong-buy” rating on shares of Oracle in a research report on Wednesday, June 18th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty-five have given a Buy rating, nine have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $304.71.

Oracle Stock Down 0.3%

NYSE ORCL opened at $282.68 on Tuesday. The company has a quick ratio of 0.62, a current ratio of 0.62 and a debt-to-equity ratio of 3.33. The company has a fifty day moving average of $258.97 and a two-hundred day moving average of $202.09. The firm has a market capitalization of $803.29 billion, a price-to-earnings ratio of 65.44, a PEG ratio of 3.05 and a beta of 1.46. Oracle Corporation has a 52 week low of $118.86 and a 52 week high of $345.72.

Oracle (NYSE:ORCL) last issued its earnings results on Tuesday, September 9th. The enterprise software provider reported $1.47 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.48 by ($0.01). The company had revenue of $14.93 billion for the quarter, compared to analysts’ expectations of $15.04 billion. Oracle had a net margin of 21.08% and a return on equity of 72.93%. The firm’s revenue for the quarter was up 12.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.39 earnings per share. Oracle has set its Q2 2026 guidance at 1.270-1.310 EPS. On average, analysts predict that Oracle Corporation will post 5 earnings per share for the current year.

Oracle Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, October 23rd. Stockholders of record on Thursday, October 9th will be paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Thursday, October 9th. Oracle’s payout ratio is currently 46.30%.

Oracle Company Profile

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.